Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Specialized Health
Fingerprint
Dive into the research topics where Khaled Chatila is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Completed
-
A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Chatila, K. (PI)
Novartis Pharmaceuticals Corporation ( Award # )
8/12/16 → 6/30/17
Project: Research project
-
Additive Cardiorenal Benefits of Finerenone and SGLT2 Inhibitor Combination Therapy in Diabetic CKD: A Propensity-Matched Real-World Study
Mortada, I., Lee, A. W., Sahu, A., Nwaogu, C., Quach, V., Mansour, S., Chatila, K., Blackwell, T. A. & Jneid, H., May 1 2026, In: American Journal of Cardiology. 266, p. 92-97 6 p.Research output: Contribution to journal › Article › peer-review
-
Association of Tirzepatide Use With Clinical Outcomes After TAVR in Obese Patients: A Propensity Score–Matched Real-World Study
Mortada, I., Quach, V., Lee, A. W., Long, N., Ebel, G., Al Abdouh, A., Albayyaa, M., Love, A., Mansour, S., Chatila, K., Shalaby, M., Blackwell, T. A. & Jneid, H., Jun 2026, In: Journal of the Society for Cardiovascular Angiography and Interventions. 5, 6, 105384.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure
Mortada, I., Paul, K., Chammany, M., Abraham, Y., Devulapally, K., Lee, A. W., Mansour, S., Chatila, K., Boyars, M. C., Jehle, D., Blackwell, T. A. & Jneid, H., 2026, In: Diabetes and Vascular Disease Research. 23, 4, p. 14791641261467888Research output: Contribution to journal › Article › peer-review
-
Differential Outcomes With Empagliflozin and Dapagliflozin in Heart Failure With Mildly Reduced Ejection Fraction With and Without Diabetes Mellitus
Mortada, I., Lee, A. W., Sahu, A., Vidal, E., Buckingham, D., Paul, K., Alhanbali, Y., Mansour, S., Chatila, K., Iturrizaga Murrieta, J., Jehle, D., Blackwell, T. A. & Jneid, H., 2026, In: American Journal of Cardiology. 271, p. 13-19 7 p.Research output: Contribution to journal › Article › peer-review
-
Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study
Mortada, I., Lee, A. W., Quach, V., Rice, J., Mansour, S., Chatila, K., Shalaby, M., Blackwell, T. & Jneid, H., Jun 1 2026, In: American Journal of Cardiology. 268, p. 19-24 6 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations